JAVMA news
Old, new deputy CEO see AVMA moving profession forward
What kept Dr. Elizabeth A. Curry-Galvin on the staff of the AVMA for two decades?
JAVMA news
Q&A with Dr. Elizabeth A. Curry-Galvin
Dr. Elizabeth A. Curry-Galvin, outgoing deputy chief executive officer of the AVMA, answers questions from JAVMA News.
policy
Guidelines for use of exempt biologics
State-licensed veterinarians may consider preparing biologics in their practice facility under a VCPR in unique disease situations not adequately…
JAVMA news
AVMA advocates against prescription mandate bill
In April, AVMA Board of Directors chair Dr. John de Jong testified before a House subcommittee about the Fairness to Pet Owners Act (HR 3174/S 1200),
JAVMA news
The slow rise of generic animal drugs
In human medicine, generic drugs accounted for 88 percent of prescriptions dispensed in the United States as of 2014.
JAVMA news
More opioids available to veterinarians during ongoing shortage
The Food and Drug Administration announced Dec. 13 that the agency has worked with Pfizer Inc. to help alleviate a shortage of certain injectable…
JAVMA news
Groups provide new guidance on antimicrobials
The AVMA, Canadian VMA, and Federation of Veterinarians of Europe are calling for continuous monitoring of antimicrobial use and resistance at a…
JAVMA news
FDA sees trend of unsafe compounding labs
Food and Drug Administration authorities say they are seeing a trend of unsafe conditions in compounding laboratories.
JAVMA news
FDA opens access to adverse event data
The Food and Drug Administration is offering data about adverse events in animals that can be useful for researchers and software developers.
policy
UNDER REVIEWAABP judicious therapeutic use of antimicrobials in cattle
The AVMA has endorsed these guidelines developed by the American Association of Bovine Practitioners.